These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17129842)

  • 1. Very high resistance to amoxicillin in Streptococcus pneumoniae: an epidemiological fact or a technical issue?
    Camacho MT; Casal J; Aguilar L; Gimenez MJ; Fenoll A
    J Chemother; 2006 Jun; 18(3):303-6. PubMed ID: 17129842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA; Farrell DJ; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin.
    Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the E-test and the ATB-PNEUMo battery for determining the beta-lactam MIC for Streptococcus pneumoniae in daily practice].
    Chomarat M; Fredenucci I; Barbé G; Boucaud-Maitre Y; Boyer M; Carricajo A; Célard M; Clergeau P; Croizé J; Delubac F; Fèvre D; Fuhrmann C; Gilles Y; Gravagna B; Helfre M; Letouzey MN; Lelièvre H; Mandjee A; Marchal MF; Marthelet P; Meley R; Perrier-Gros-Claude JD; Bercion R; Reverdy ME; Ros A; Roure C; Sabot O; Smati S; Thierry J; Tixier A; Tous J; Verger P; Zaoui E
    Pathol Biol (Paris); 2001 Sep; 49(7):548-52. PubMed ID: 11642017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens.
    Odenholt I; Cars O; Löwdin E
    J Antimicrob Chemother; 2004 Dec; 54(6):1062-6. PubMed ID: 15563517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation.
    Sevillano D; Calvo A; Giménez MJ; Alou L; Aguilar L; Valero E; Carcas A; Prieto J
    J Antimicrob Chemother; 2004 Dec; 54(6):1148-51. PubMed ID: 15489246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the results of the Etest and the method for determining minimum inhibitory concentrations in solid media for penicillin G, amoxicillin, and cefotaxime for S. pneumoniae. A multicenter study].
    Clavier B; Perrier-Gros-Claude JD; Foissaud V; Dumas M; Aubert G; Barbé G; Bland S; Boucaud Maitre Y; Boyer M; Chomarat M; Clergeau P; Delubac F; Févre D; Fuhrmann C; Gravagnat B; Letouzey MN; Mandjee A; Martelet P; Meley R; Reverdy ME; Ros A; Roure C; Sabot O; Tixier A; Thierry J
    Pathol Biol (Paris); 1998 Jun; 46(6):369-74. PubMed ID: 9769863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Castanheira M; Gales AC; Pignatari AC; Jones RN; Sader HS
    Microb Drug Resist; 2006; 12(2):91-8. PubMed ID: 16922623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials.
    Tomás I; Tomás M; Alvarez M; Velasco D; Potel C; Limeres J; Diz P
    Oral Microbiol Immunol; 2007 Oct; 22(5):298-303. PubMed ID: 17803626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of pneumolysin and autolysin genes among antibiotic resistant Streptococcus pneumoniae in invasive infections.
    Sourav S; Patricia A; Sharma S; Kanungo R; Jayachandran S; Prashanth K
    Indian J Med Microbiol; 2010; 28(1):34-9. PubMed ID: 20061761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates.
    Drago L; De Vecchi E; Nicola L; Legnani D; Prenna M; Ripa S
    J Chemother; 2005 Apr; 17(2):161-8. PubMed ID: 15920900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ex-vivo pharmacodynamic study comparing bactericidal activity of amoxicillin/sulbactam, azithromycin, doxycycline and levofloxacin against Streptococcus pneumoniae.
    Bantar C; Nicola F; Arenoso H; Soutric J; Caruso N; Fernández Canigia L
    J Chemother; 2004 Jun; 16(3):248-54. PubMed ID: 15330320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains.
    Azoulay-Dupuis E; Moine P; Bedos JP; Rieux V; Vallee E
    Antimicrob Agents Chemother; 1996 Apr; 40(4):941-6. PubMed ID: 8849256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
    Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
    J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of susceptibility test methods to detect penicillin susceptibility in Streptococcus pneumoniae isolates.
    Mohd Nasir MD; Parasakthi N
    Malays J Pathol; 2004 Jun; 26(1):29-33. PubMed ID: 16190104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.